FDA Greenlights a CRISPR-Based Test to Diagnose Covid-19

The test gives a result within an hour

Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Credit: NIAID

A test that can diagnose the coronavirus within an hour using the gene-editing technology known as CRISPR has received emergency use authorization from the U.S. Food and Drug Administration.

The test was developed by Sherlock Biosciences, a biotech company launched in March 2019…

--

--

--

A blog from Medium for Covid-19 news, advice, and commentary.

Recommended from Medium

This Will Only Be Over When We Say It’s Over

28 companies, including tech firms, collaborate on EHR-fueled COVID-19 database

Plasma From Coronavirus Survivors Could Treat Current Patients

Top medical advisers arguing hard for tighter coronavirus restrictions

Working in a Hospital Supply Room During the Pandemic

Ideas for Communicating with the Public on COVID-19 Best Practices

An MIT Professor on the Covid Vaccine Supply Chain

[PDF] Download Malt Whisky Yearbook 2015 Ebook_File by :Ingvar Ronde

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Emily Mullin

Emily Mullin

Former staff writer at Medium, where I covered biotech, genetics, and Covid-19 for OneZero, Future Human, Elemental, and the Coronavirus Blog.

More from Medium

Mets Sweep Nats Behind Big Day

Yes, a Handful of Prehistoric Geniuses Launched Humanity’s Technological Revolution

Mike Savage New Canaan The Future of the Muscle Car

GFI Founder’s Update-February 2022